Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Doctors Man is a Japanese healthcare company specializing in the development and commercialization of hydrogen-based therapeutic devices. The company's flagship product, Suisonia, is a hydrogen-oxygen inhaler used in both clinical and wellness settings to address oxidative stress and improve overall health. Doctors Man collaborates with academic institutions, such as Keio University, to conduct clinical research on the efficacy of hydrogen inhalation for various medical conditions including respiratory and cardiovascular diseases. Their business model encompasses the manufacturing of inhalation devices, the operation of hydrogen therapy lounges, and the distribution of hydrogen-related wellness products. The company's proprietary technology utilizes a steam reduction method to generate hydrogen, distinguishing it from traditional electrolysis-based systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Doctors Man.